news Targeted drug found to combat certain pancreatic tumours 15 June 2021 | By Victoria Rees (Drug Target Review) Researchers have found that the CDK inhibitor AT7519 could be used to treat pancreatic cancer patients whose tumours are addicted to mutant KRAS.